Related Experiment Videos
Acrobeads test as a predictor of fertilization in vitro
A Hershlag1, T Paine, G M Scholl
1Department of Obstetrics and Gynecology, North Shore University Hospital-New York University School of Medicine, Manhasset 11030, USA.
Summary
The Acrobeads test does not accurately predict in vitro fertilization (IVF) success. This study found no correlation between Acrobeads scores and fertilization rates, questioning its clinical utility for IVF patient screening.
Area of Science:
- Reproductive biology
- In vitro fertilization (IVF)
Background:
- The Acrobeads test assesses CD46 expression to evaluate acrosome reaction status.
- Accurate prediction of fertilization potential is crucial for optimizing IVF outcomes.
Purpose of the Study:
- To validate the Acrobeads test's ability to predict fertilization rates in conventional IVF.
- To compare Acrobeads test results with spontaneous acrosome reaction measurements.
Main Methods:
- Prospective, double-blinded study involving 97 patients undergoing IVF.
- Acrobeads test performed on semen specimens.
- Comparison with TRITC-PSA staining for spontaneous acrosome reactions.
- Correlation analysis with fertilization rates of metaphase II oocytes.
Main Results:
- Acrobeads test scores showed no significant correlation with fertilization rates at 6h or 24h.
- The negative predictive value of the Acrobeads test was 21.4%.
- No correlation was found between Acrobeads scores and spontaneous acrosome reactions; however, TRITC-PSA results correlated with fertilization.
Conclusions:
- The Acrobeads test is not a reliable predictor of IVF fertilization outcomes.
- Routine use of the Acrobeads test for patient screening before IVF is not recommended.
- Alternative methods for assessing sperm function may be necessary for guiding treatment decisions like ICSI.